CD274 and neoplasm: Immunohistochemistry (IHC) analysis of the biopsy sample from the lung tumor demonstrated 1% PD‐L1 expression on tumor cells (clone 22C3, Dako) (Figure 1(a),(b)), and no druggable driver mutations were observed.